StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research report sent to investors on Friday. The brokerage issued a hold rating on the medical device company’s stock.
Avinger Stock Performance
Shares of AVGR opened at $0.83 on Friday. The firm has a fifty day moving average of $1.03 and a 200-day moving average of $1.91. The company has a market cap of $1.41 million, a price-to-earnings ratio of -0.05 and a beta of 1.17. Avinger has a 1 year low of $0.76 and a 1 year high of $5.45.
Avinger (NASDAQ:AVGR – Get Free Report) last posted its earnings results on Thursday, August 8th. The medical device company reported ($2.82) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The business had revenue of $1.85 million for the quarter, compared to analysts’ expectations of $2.55 million. Analysts predict that Avinger will post -4.69 EPS for the current year.
Institutional Trading of Avinger
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Further Reading
- Five stocks we like better than Avinger
- How to Plot Fibonacci Price Inflection Levels
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Learn Technical Analysis Skills to Master the Stock Market
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Utilities Stocks Explained – How and Why to Invest in Utilities
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.